Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFT/LV adjuvant feasibility study in patients aged 80 years or older with stage III colorectal cancer
jRCTs061180087Active, not recruiting
- Sponsor
- Hiroshima Surgical Study Group of Clinical Oncology
- Start
- Dec 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur + uracil and folinic acid in colorectal cancer (CRC), sponsored by Hiroshima Surgical Study Group of Clinical Oncology. Primary endpoint: Feasibility. Started Dec 2013; status: active, not recruiting.
02
Drugs
tegafur + uracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs061180087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180087.